Cercano Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Cercano Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$348K	Hold	780	–	–	0.02%	109
2025 Q4	$354K	Hold	780	–	–	0.01%	112
2025 Q3	$305K	Hold	780	–	–	0.01%	126
2025 Q2	$347K	Hold	780	–	–	0.01%	120
2025 Q1	$378K	Hold	780	–	–	0.01%	113
2024 Q4	$314K	Sell	780 -62,577	-99%	-$29M	0.01%	142
2024 Q3	$29.5M	Sell	63,357 -7,602	-11%	-$3.65M	0.7%	38
2024 Q2	$33.3M	Buy	70,959 +426	+0.6%	+$185K	0.89%	34
2024 Q1	$29.5M	Buy	70,533 +311	+0.4%	+$131K	0.82%	35
2023 Q4	$28.6M	Hold	70,222	–	–	0.94%	29
2023 Q3	$24.4M	Hold	70,222	–	–	0.87%	33
2023 Q2	$24.7M	Buy	70,222 +5,101	+8%	+$1.72M	0.86%	31
2023 Q1	$20.5M	Sell	65,121 -3,329	-5%	-$998K	0.82%	25
2022 Q4	$19.8M	Buy	+68,450	New	+$20.9M	0.8%	27

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cercano Management's VRTX Position: Q1 2026 in Review

Cercano Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 780 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #109.

Cercano Management first reported a position in VRTX in Q4 2022 and has held it in 14 quarters since. The position peaked at $33.3M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Cercano Management held 780 shares of Vertex Pharmaceuticals worth $348K as of Q1 2026.
Cercano Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
Vertex Pharmaceuticals made up 0.02% of Cercano Management's portfolio in Q1 2026, its #109 holding.
Cercano Management first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
Cercano Management's Vertex Pharmaceuticals position peaked at $33.3M in Q2 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Cercano Management's 13F filing for Q1 2026, filed 13 May 2026.